|
1
|
Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial.
|
Lancet Oncol
|
2006
|
6.92
|
|
2
|
Genomics identifies medulloblastoma subgroups that are enriched for specific genetic alterations.
|
J Clin Oncol
|
2006
|
5.96
|
|
3
|
Neurocognitive consequences of risk-adapted therapy for childhood medulloblastoma.
|
J Clin Oncol
|
2005
|
2.34
|
|
4
|
Clinical, histopathologic, and molecular markers of prognosis: toward a new disease risk stratification system for medulloblastoma.
|
J Clin Oncol
|
2004
|
2.16
|
|
5
|
Amifostine protects against cisplatin-induced ototoxicity in children with average-risk medulloblastoma.
|
J Clin Oncol
|
2008
|
1.87
|
|
6
|
Radiation-induced malignant gliomas: is there a role for reirradiation?
|
Int J Radiat Oncol Biol Phys
|
2008
|
1.76
|
|
7
|
Direct orthotopic transplantation of fresh surgical specimen preserves CD133+ tumor cells in clinically relevant mouse models of medulloblastoma and glioma.
|
Stem Cells
|
2008
|
1.64
|
|
8
|
Hypomethylation and hypermethylation of DNA in Wilms tumors.
|
Oncogene
|
2002
|
1.59
|
|
9
|
Implications of tumor location on subtypes of medulloblastoma.
|
Pediatr Blood Cancer
|
2013
|
1.57
|
|
10
|
Expression profiles of osteosarcoma that can predict response to chemotherapy.
|
Cancer Res
|
2005
|
1.49
|
|
11
|
Response of retinoblastoma with vitreous tumor seeding to adenovirus-mediated delivery of thymidine kinase followed by ganciclovir.
|
J Clin Oncol
|
2005
|
1.46
|
|
12
|
Acquired von Willebrand syndrome and Wilms tumor: not always benign.
|
Pediatr Blood Cancer
|
2009
|
1.45
|
|
13
|
Temozolomide after radiotherapy for newly diagnosed high-grade glioma and unfavorable low-grade glioma in children.
|
J Neurooncol
|
2006
|
1.38
|
|
14
|
Frequent amplification and rearrangement of chromosomal bands 6p12-p21 and 17p11.2 in osteosarcoma.
|
Genes Chromosomes Cancer
|
2004
|
1.34
|
|
15
|
Genome-wide allelic imbalance analysis of pediatric gliomas by single nucleotide polymorphic allele array.
|
Cancer Res
|
2006
|
1.31
|
|
16
|
A clinically relevant orthotopic xenograft model of ependymoma that maintains the genomic signature of the primary tumor and preserves cancer stem cells in vivo.
|
Neuro Oncol
|
2010
|
1.24
|
|
17
|
Absence of systemic immune response to adenovectors after intraocular administration to children with retinoblastoma.
|
Mol Ther
|
2010
|
1.23
|
|
18
|
Phase I study of vismodegib in children with recurrent or refractory medulloblastoma: a pediatric brain tumor consortium study.
|
Clin Cancer Res
|
2013
|
1.20
|
|
19
|
Cell cycle regulator gene CDC5L, a potential target for 6p12-p21 amplicon in osteosarcoma.
|
Mol Cancer Res
|
2008
|
1.16
|
|
20
|
Role of temozolomide after radiotherapy for newly diagnosed diffuse brainstem glioma in children: results of a multiinstitutional study (SJHG-98).
|
Cancer
|
2005
|
1.12
|
|
21
|
Proceedings of the consensus meetings from the International Retinoblastoma Staging Working Group on the pathology guidelines for the examination of enucleated eyes and evaluation of prognostic risk factors in retinoblastoma.
|
Arch Pathol Lab Med
|
2009
|
1.12
|
|
22
|
Expression analysis of juvenile pilocytic astrocytomas by oligonucleotide microarray reveals two potential subgroups.
|
Cancer Res
|
2005
|
1.09
|
|
23
|
FOXG1 dysregulation is a frequent event in medulloblastoma.
|
J Neurooncol
|
2007
|
1.08
|
|
24
|
Satellite DNA hypomethylation in karyotyped Wilms tumors.
|
Cancer Genet Cytogenet
|
2003
|
1.05
|
|
25
|
Local control after intensity-modulated radiotherapy for head-and-neck rhabdomyosarcoma.
|
Int J Radiat Oncol Biol Phys
|
2008
|
1.02
|
|
26
|
Results of a phase II upfront window of pharmacokinetically guided topotecan in high-risk medulloblastoma and supratentorial primitive neuroectodermal tumor.
|
J Clin Oncol
|
2004
|
1.02
|
|
27
|
Identification of a plasma proteomic signature to distinguish pediatric osteosarcoma from benign osteochondroma.
|
Proteomics
|
2006
|
1.02
|
|
28
|
White matter lesions detected by magnetic resonance imaging after radiotherapy and high-dose chemotherapy in children with medulloblastoma or primitive neuroectodermal tumor.
|
J Clin Oncol
|
2004
|
1.02
|
|
29
|
Infantile fibrosarcoma: clinical and histologic responses to cytotoxic chemotherapy.
|
Pediatr Blood Cancer
|
2009
|
1.01
|
|
30
|
A single intravenous injection of oncolytic picornavirus SVV-001 eliminates medulloblastomas in primary tumor-based orthotopic xenograft mouse models.
|
Neuro Oncol
|
2010
|
1.00
|
|
31
|
Glutathione S-transferase M1 and T1 polymorphisms may predict adverse effects after therapy in children with medulloblastoma.
|
Neuro Oncol
|
2008
|
0.99
|
|
32
|
Topotecan is active against Wilms' tumor: results of a multi-institutional phase II study.
|
J Clin Oncol
|
2007
|
0.95
|
|
33
|
Intravenous injection of oncolytic picornavirus SVV-001 prolongs animal survival in a panel of primary tumor-based orthotopic xenograft mouse models of pediatric glioma.
|
Neuro Oncol
|
2013
|
0.95
|
|
34
|
Low early ototoxicity rates for pediatric medulloblastoma patients treated with proton radiotherapy.
|
Radiat Oncol
|
2011
|
0.94
|
|
35
|
Ototoxicity after intensity-modulated radiation therapy and cisplatin-based chemotherapy in children with medulloblastoma.
|
Int J Radiat Oncol Biol Phys
|
2010
|
0.93
|
|
36
|
A single institution experience with pediatric nasopharyngeal carcinoma: high incidence of toxicity associated with platinum-based chemotherapy plus IMRT.
|
J Pediatr Hematol Oncol
|
2007
|
0.91
|
|
37
|
Expression of oligodendroglial differentiation markers in pilocytic astrocytomas identifies two clinical subsets and shows a significant correlation with proliferation index and progression free survival.
|
J Neurooncol
|
2007
|
0.91
|
|
38
|
Anaplastic ganglioglioma arising from a Lhermitte-Duclos-like lesion. Case report.
|
J Neurosurg
|
2007
|
0.90
|
|
39
|
Local control after craniospinal irradiation, intensity-modulated radiotherapy boost, and chemotherapy in childhood medulloblastoma.
|
Cancer
|
2010
|
0.89
|
|
40
|
Prenatal presentation and outcome of children with pleuropulmonary blastoma.
|
J Pediatr Surg
|
2006
|
0.88
|
|
41
|
Plasma proteome predicts chemotherapy response in osteosarcoma patients.
|
Oncol Rep
|
2010
|
0.87
|
|
42
|
Intensity-modulated radiation therapy in childhood ependymoma.
|
Int J Radiat Oncol Biol Phys
|
2008
|
0.87
|
|
43
|
Outcome of patients with pilocytic astrocytoma and leptomeningeal dissemination.
|
Int J Radiat Oncol Biol Phys
|
2012
|
0.87
|
|
44
|
High-dose chemotherapy with autologous hematopoietic stem cell rescue for stage 4B retinoblastoma.
|
Pediatr Blood Cancer
|
2010
|
0.86
|
|
45
|
Lesion regression.
|
J Neurosurg
|
2007
|
0.86
|
|
46
|
Sinonasal teratocarcinosarcoma in an adolescent male.
|
J Pediatr Hematol Oncol
|
2012
|
0.85
|
|
47
|
Targeted therapy in bone and soft tissue sarcoma in children and adolescents.
|
Curr Oncol Rep
|
2012
|
0.85
|
|
48
|
Long-term outcome of centrally located low-grade glioma in children.
|
Cancer
|
2013
|
0.84
|
|
49
|
Pilot study of systemic and intrathecal mafosfamide followed by conformal radiation for infants with intracranial central nervous system tumors: a pediatric brain tumor consortium study (PBTC-001).
|
J Neurooncol
|
2012
|
0.83
|
|
50
|
Outcomes of integrating genetics in management of patients with retinoblastoma.
|
Arch Ophthalmol
|
2011
|
0.83
|
|
51
|
Elevated expression of CXC chemokines in pediatric osteosarcoma patients.
|
Cancer
|
2010
|
0.83
|
|
52
|
Intensity-modulated radiotherapy (IMRT) in pediatric low-grade glioma.
|
Cancer
|
2013
|
0.83
|
|
53
|
Children's Oncology Group's 2013 blueprint for research: rare tumors.
|
Pediatr Blood Cancer
|
2012
|
0.82
|
|
54
|
Low-level copy gain versus amplification of myc oncogenes in medulloblastoma: utility in predicting prognosis and survival. Laboratory investigation.
|
J Neurosurg Pediatr
|
2009
|
0.80
|
|
55
|
Results of treatment of patients with superficial facial rhabdomyosarcomas on protocols of the Intergroup Rhabdomyosarcoma Study Group (IRSG), 1984-1997.
|
Pediatr Blood Cancer
|
2008
|
0.80
|
|
56
|
Retinoblastoma: from bench to bedside.
|
Expert Rev Mol Med
|
2003
|
0.80
|
|
57
|
Changes mimicking new leptomeningeal disease after intensity-modulated radiotherapy for medulloblastoma.
|
Int J Radiat Oncol Biol Phys
|
2008
|
0.79
|
|
58
|
Renal and hepatic tumors in the neonatal period.
|
Semin Fetal Neonatal Med
|
2012
|
0.79
|
|
59
|
Leukaemia & cancer in neonates.
|
Semin Fetal Neonatal Med
|
2012
|
0.79
|
|
60
|
Integrated multimodal genetic testing of Ewing sarcoma--a single-institution experience.
|
Hum Pathol
|
2013
|
0.78
|
|
61
|
Medulloblastoma and juvenile pilocytic astrocytoma presenting as synchronous primary brain tumors in a child: case report.
|
J Neurosurg Pediatr
|
2010
|
0.77
|
|
62
|
Low-grade myofibroblastic sarcoma of the sacrum.
|
J Neurosurg Pediatr
|
2010
|
0.77
|
|
63
|
Silencing BMI1 eliminates tumor formation of pediatric glioma CD133+ cells not by affecting known targets but by down-regulating a novel set of core genes.
|
Acta Neuropathol Commun
|
2014
|
0.77
|
|
64
|
Extensively necrotic retinoblastoma is associated with high-risk prognostic factors.
|
Arch Pathol Lab Med
|
2006
|
0.77
|
|
65
|
Concordance between the chang and the International Society of Pediatric Oncology (SIOP) ototoxicity grading scales in patients treated with cisplatin for medulloblastoma.
|
Pediatr Blood Cancer
|
2013
|
0.77
|
|
66
|
Corrigendum: Common variants in ACYP2 influence susceptibility to cisplatin-induced hearing loss.
|
Nat Genet
|
2015
|
0.77
|
|
67
|
Residual intraretinal retinoblastoma after chemoreduction failure.
|
Arch Ophthalmol
|
2012
|
0.76
|
|
68
|
Phase I trial of capecitabine rapidly disintegrating tablets and concomitant radiation therapy in children with newly diagnosed brainstem gliomas and high-grade gliomas.
|
Neuro Oncol
|
2013
|
0.75
|
|
69
|
Mutations of PTCH1, MLL2, and MLL3 are not frequent events in hepatoblastoma.
|
Pediatr Blood Cancer
|
2011
|
0.75
|
|
70
|
Neuroendocrine Tumor of the Appendix in Children.
|
J Pediatr Hematol Oncol
|
2017
|
0.75
|
|
71
|
Secondary glioblastoma multiform in a patient with CHARGE syndrome and prior radiation therapy for medulloblastoma.
|
Pediatr Hematol Oncol
|
2014
|
0.75
|
|
72
|
Myofibroma in Infancy and Childhood.
|
J Pediatr Hematol Oncol
|
2017
|
0.75
|
|
73
|
Therapeutic implications of CD1d expression and tumor-infiltrating macrophages in pediatric medulloblastomas.
|
J Neurooncol
|
2014
|
0.75
|